Anti-Toxoplasma gondii activities and structure-activity relationships of novel fluoroquinolones related to trovafloxacin.
Anti-Toxoplasma gondii activities and structure-activity relationships of novel fluoroquinolones related to trovafloxacin.
复制标题
与曲伐沙星相关的新型氟喹诺酮类药物的抗弓形虫活性和构效关系。
DOI:
10.1128/aac.43.7.1783
复制
发表时间:
1999
影响因子:
4.9
通讯作者:
Remington,JS
中科院分区:
文献类型:
--
作者:
Khan,AA;Araujo,FG;Brighty,KE;Gootz,TD;Remington,JS
Eleven novel fluoroquinolones closely related to trovafloxacin were evaluated for their in vitro activity againstToxoplasma gondii, and their structure-activity relationships were examined. The 50% inhibitory concentration (IC50) of trovafloxacin againstT. gondiiwas 2.93 μM; the IC50of the 11 analogs ranged from 0.53 to 14.09 μM. Six analogs had IC50s lower than that of trovafloxacin. Examination of the structure-activity relationships of the compounds revealed that addition of a -CH3at C-5 of the 1,8-naphthyridone ring, at C-2 of the azabicyclohexane ring, or on the -NH2at the 6 position of the azabicyclohexane ring resulted in a four- to sixfold increase in activity. Moreover, replacement of 2,4-difluorophenyl by cyclopropyl at N-1 of the 1,8-naphthyridone ring increased activity twofold, and moving the -NH2one atom further away from the azabicyclohexane ring decreased activity. There was no difference between the naphthyridone and quinolone analogs. These results indicate that structure-activity studies of compounds related to drugs active againstT. gondiimay be useful in producing compounds with more potent activities against the parasite.